Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Sensorion to host a webconference dedicated to its retail shareholders on October 10, 2024, in French, at 6pm CET (12pm ET) Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering...
Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within...
Sensorion rapporte des données initiales de sécurité positives sur le premier patient injecté dans Audiogene, son essai clinique de thérapie génique en Phase 1/2 du SENS-501 Sensorion annonce...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.032 | 4.84848484848 | 0.66 | 0.77 | 0.584 | 39847 | 0.63140041 | DE |
4 | -0.024 | -3.35195530726 | 0.716 | 0.77 | 0.584 | 33239 | 0.67992118 | DE |
12 | 0 | 0 | 0.692 | 0.97 | 0.584 | 60709 | 0.79856446 | DE |
26 | -0.092 | -11.7346938776 | 0.784 | 0.97 | 0.57 | 42556 | 0.76027906 | DE |
52 | 0.162 | 30.5660377358 | 0.53 | 1.04 | 0.403 | 64542 | 0.72338513 | DE |
156 | -1.036 | -59.9537037037 | 1.728 | 2.29 | 0.26 | 76978 | 0.70488072 | DE |
260 | -0.388 | -35.9259259259 | 1.08 | 2.665 | 0.26 | 88624 | 1.09417213 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約